Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Retinoblastoma × Cytapheresis × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1 Recurrence 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

Carboplatin 20 Etoposide 17 Vincristine 14 Filgrastim 11 Melphalan 10 Topotecan 9 Granulocyte Colony-Stimulating Factor 9 Cyclophosphamide 9 Thiotepa 6 Cryotherapy 5 Mesna 4 Busulfan 4 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Ifosfamide 3 Drug Therapy 3 Doxorubicin 3 Temozolomide 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 etoposide phosphate 1 cixutumumab 1 becatecarin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡